The amount of outstanding funds that the entity is obligated to repay.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 55
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_Borrowings
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The interest rate on borrowings. [Refer: Borrowings]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 7
-IssueDate 2021-01-01
-Paragraph 7
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_BorrowingsInterestRate
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of expense arising from interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2021-01-01
-Paragraph 23
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2021-01-01
-Paragraph 28
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2021-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph B13
-Subparagraph f
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_InterestExpense
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net debt of the entity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 112
-Subparagraph c
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_NetDebt
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number of shares issued by the entity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 106
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_NumberOfSharesIssued
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Conversion price.

+ References

No definition available.

+ Details

Name:	sprcy_ConversionPrice
Namespace Prefix:	sprcy_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	sprcy_ConvertibleLoansDetailsLineItems
Namespace Prefix:	sprcy_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	sprcy_DebtInstrumentsMaturityDate
Namespace Prefix:	sprcy_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Description of conversion loan.

+ References

No definition available.

+ Details

Name:	sprcy_DescriptionOfConversionLoan
Namespace Prefix:	sprcy_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Purchase value.

+ References

No definition available.

+ Details

Name:	sprcy_PurchaseValue
Namespace Prefix:	sprcy_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	sprcy_TypesOfAgreementAxis=sprcy_SecuritiesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BorrowingsByNameAxis=sprcy_DekelPharmaceuticalLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ComponentsOfEquityAxis=sprcy_AmericanDepositorySharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BorrowingsByNameAxis=sprcy_TrancheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Convertible Loans (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended
	Apr. 17, 2020	Mar. 19, 2020	Jun. 30, 2021	Mar. 04, 2021	Nov. 20, 2020	Jan. 15, 2020
Convertible Loans (Details) [Line Items]
Convertible loan amount						$ 50
Interest	$ 2
Warrant to purchase (in Shares)			14,000,000	916,316	835,447
bear interest rate		12.00%
Maturity date		Mar. 23, 2021
Securities Purchase Agreement [Member] \| Dekel Pharmaceutical Ltd [Member]
Convertible Loans (Details) [Line Items]
Original principal amount		$ 350,000
Purchase value		$ 315,000
ADS [Member]
Convertible Loans (Details) [Line Items]
Conversion Price (in Dollars per share)		$ 24.50
Warrant [Member] \| Tranche [Member]
Convertible Loans (Details) [Line Items]
Original principal amount		$ 220,000
Purchase value		$ 198,000
Warrant [Member] \| Private Placement [Member]
Convertible Loans (Details) [Line Items]
Warrant to purchase (in Shares)		571
Warrant [Member] \| ADS [Member]
Convertible Loans (Details) [Line Items]
Warrant to purchase (in Shares)		4,490
Description of conversion loan		After the six-month anniversary of the issuance of the Notes, the conversion price shall be equal to the lower of the Fixed Conversion Price or 70% of the lowest trading price of the ADSs as reported on Nasdaq or any exchange upon which the ADSs or ordinary shares of the Company are traded at such time, for the 20 prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. The Private Placement Warrant is exercisable at any time on or after the actual closing date and on or prior to the close of business on the five-year anniversary of the date of issuance, at an initial exercise price of $24.50 per ADS, subject to adjustment.